Delivery Order SPE2DB24D2010-SPE2DB25FZWU0

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRYCEL 100 MG TABLET 30S. The contract, valued at $10,645.34, is a firm fixed-price delivery order with a period of performance through November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This is a delivery order federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $33,236.92 and a period of performance through March 7, 2025. The contract is a firm fixed price delivery order, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRYCEL 100 MG TABLET 30S. The contract has a firm fixed price of $13,436.87 and an ultimate completion date of July 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of SPRYCEL 50 MG TABLET 60S, a specialty medication. The contract has a ceiling value of $25,133.30 and a completion date of January 10, 2024. The contract is a Firm Fixed Price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $10,645.34 firm fixed-price contract is for the supply of SPRYCEL 100 MG TABLET 30S, a prescription medication, with a period of performance through September 10, 2024. This contract is not a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply SPRYCEL 100 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $20,097.49 and a performance period ending on September 16, 2024. It is a firm-fixed-price contract and does not have any set-aside designations. This delivery order is part of a larger indefinite delivery contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,171.94, is for the delivery of SPRYCEL 70 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price contract type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sprycel 100 mg tablets. The contract has a ceiling value of $26,613.30 and an ultimate completion date of September 30, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,890.40, is for the supply of SPRYCEL 140 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of December 10, 2024 and is a firm fixed-price delivery order. This contract is not associated with a set-aside requirement. AmerisourceBergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,151.23 firm fixed-price delivery order contract is for the supply of SPRYCEL 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZWU0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of SPRYCEL 100 MG TABLET 30S. The contract has a ceiling value of $5,506.62 and runs through March 25, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/29/25, 12:55 AM